Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Aoki

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Scientific Reports|November 2, 2024
Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation modelAkira Saito, Toshiyuki Koya, Ami Aoki, et al.
Respiratory Investigation|September 1, 2024
Prevalence and characteristics of dysfunctional breathing in patients with asthma in the Japanese populationNatsuki Takeda, Toshiyuki Koya, Takashi Hasegawa, et al.
Nature Immunology|October 9, 2019
CD103<sup>hi</sup> T<sub>reg</sub> cells constrain lung fibrosis induced by CD103<sup>lo</sup> tissue-resident pathogenic CD4 T cellsTomomi Ichikawa, Kiyoshi Hirahara, Kota Kokubo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2017
Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial DiseaseAmi Aoki, Takuro Sakagami, Kazutaka Yoshizawa, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2019
Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathologyDamon Tumes, Kiyoshi Hirahara, Magdalene Papadopoulos, et al.
Cancers|January 8, 2023
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory <i>ALK</i>-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)Satoshi Watanabe, Kazuko Sakai, Naoya Matsumoto, et al.
Science Immunology|October 24, 2025
Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunityHiroyuki Yagyu, Masahiro Kiuchi, Atsushi Sasaki, et al.
ERJ Open Research|February 4, 2020
Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kitKoh Nakata, Tatsuki Sugi, Keiko Kuroda, et al.
Journal of Clinical Immunology|April 22, 2024
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 PatientsAmi Aoki, Chiaki Iwamura, Masahiro Kiuchi, et al.
Science (New York, N.Y.)|December 11, 2025
Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4<sup>+</sup> T cellsMasahiro Kiuchi, Masahiro Nemoto, Hiroyuki Yagyu, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 2, 2024
Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation modelAkira Saito, Toshiyuki Koya, Ami Aoki, et al.
Respiratory Investigation|September 1, 2024
Prevalence and characteristics of dysfunctional breathing in patients with asthma in the Japanese populationNatsuki Takeda, Toshiyuki Koya, Takashi Hasegawa, et al.
Nature Immunology|October 9, 2019
CD103<sup>hi</sup> T<sub>reg</sub> cells constrain lung fibrosis induced by CD103<sup>lo</sup> tissue-resident pathogenic CD4 T cellsTomomi Ichikawa, Kiyoshi Hirahara, Kota Kokubo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2017
Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial DiseaseAmi Aoki, Takuro Sakagami, Kazutaka Yoshizawa, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2019
Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathologyDamon Tumes, Kiyoshi Hirahara, Magdalene Papadopoulos, et al.
Cancers|January 8, 2023
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory <i>ALK</i>-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)Satoshi Watanabe, Kazuko Sakai, Naoya Matsumoto, et al.
Science Immunology|October 24, 2025
Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunityHiroyuki Yagyu, Masahiro Kiuchi, Atsushi Sasaki, et al.
ERJ Open Research|February 4, 2020
Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kitKoh Nakata, Tatsuki Sugi, Keiko Kuroda, et al.
Journal of Clinical Immunology|April 22, 2024
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 PatientsAmi Aoki, Chiaki Iwamura, Masahiro Kiuchi, et al.
Science (New York, N.Y.)|December 11, 2025
Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4<sup>+</sup> T cellsMasahiro Kiuchi, Masahiro Nemoto, Hiroyuki Yagyu, et al.
Pageof 5